Email Newsletters

Banking & Finance

Networking meetings are like moths to light

Networking meetings are well marketed. They offer the promise of that one connection that will lead to business.

Webster Five wants $1B the right way

Donald Doyle took over leadership of Webster Five in May 2016, looking to transition the community mutual bank into the future. This March, the company is set to celebrate its 150th anniversary while it prepares for a time when most of its assets will be from Millennials.

Main Street Bank names, promotes CFO, COO

Main Street Bank in Marlborough on Friday announced it promoted two long-time executives to be its executive vice president and chief operating officer.

As the banking industry consolidates, loans will increase

With the American economy humming along at a steady rate – with job rates, household spending and consumer confidence all up – financial institutions lent more in 2017 than at any year since before the Great Recession, according to the Federal Reserve.
ADVERTISEMENT

Know How: Busting your pre-conceived money myths

Financial literacy should be taught in school, but is rarely spoken about in the home. As a result, most people get their education in bits and pieces.

Westborough firm is in business to destroy

Fifty years ago, Len Rosen founded Security Engineered Machinery, providing destruction for top-secret government documents and commercial clients.

Protect against identity theft and fraud

Computer information about you lives forever and can be the source of identity theft or even an accidental identity change.

Venture capitalist named as UMass Medical vice chancellor

Prominent venture capitalist Jim Glasheen will join UMass Medical School on Dec. 4 as the executive vice chancellor for innovation and business development.
ADVERTISEMENT

Mass. economy grows by 6 percent

While consumer spending has been "surprisingly weak," the Massachusetts economy jolted forward in the third quarter.

Holliston biotech delisted from NASDAQ

Holliston biotechnology firm Biostage, Inc. was delisted from the NASDAQ on Friday because its stock price was too low.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA